Peer Review reports
From: Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
| Original Submission | ||
|---|---|---|
| 14 Nov 2017 | Submitted | Original manuscript |
| 10 Feb 2018 | Reviewed | Reviewer Report - Sophia Ran |
| 20 Feb 2018 | Reviewed | Reviewer Report - Joseph A. Sparano |
| 22 Apr 2018 | Author responded | Author comments - Alexandra Harris |
| Resubmission - Version 2 | ||
| 22 Apr 2018 | Submitted | Manuscript version 2 |
| 24 May 2018 | Reviewed | Reviewer Report - Sophia Ran |
| 12 Jun 2018 | Author responded | Author comments - Alexandra Harris |
| Resubmission - Version 3 | ||
| 12 Jun 2018 | Submitted | Manuscript version 3 |
| Publishing | ||
| 20 Jun 2018 | Editorially accepted | |
| 6 Jul 2018 | Article published | 10.1186/s12885-018-4619-8 |
You can find further information about peer review here.